��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
大山(1615)
月營收
季盈餘
2025/02/01
59.70元 (大山股價)
2025/02/01
34.87% (年增率)
606百萬元 (營收)
大山(1615) 年度營收走勢圖
12
395百萬/月 (110年)
529百萬/月 (111年)
576百萬/月 (112年)
601百萬/月 (113年)
N/A百萬/月 (114年)
大山(1615)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/02
606,204
118.38%
449,479
34.87%
883,795
18.87%
114/01
277,591
-53.89%
294,015
-5.59%
277,591
-5.59%
113/12
601,962
65.46%
576,895
4.35%
5,869,663
18.71%
113/11
363,820
-27.14%
437,319
-16.81%
5,267,701
20.61%
113/10
499,356
3.72%
429,707
16.21%
4,903,881
24.77%
113/09
481,466
-27.50%
469,649
2.52%
4,404,525
25.82%
113/08
664,055
23.40%
472,133
40.65%
3,923,059
29.43%
113/07
538,131
35.71%
500,804
7.45%
3,259,004
27.36%
113/06
396,527
-10.62%
383,148
3.49%
2,720,873
32.20%
113/05
443,663
-23.31%
297,594
49.08%
2,324,346
38.77%
113/04
578,534
3.56%
310,062
86.59%
1,880,683
36.55%
113/03
558,655
24.29%
565,717
-1.25%
1,302,149
22.01%
113/02
449,479
52.88%
294,217
52.77%
743,494
48.24%
113/01
294,015
-49.03%
207,339
41.80%
294,015
41.80%
112/12
576,895
31.92%
529,050
9.04%
4,944,584
11.55%
112/11
437,319
1.77%
403,723
8.32%
4,367,689
11.88%
112/10
429,707
-8.50%
408,602
5.17%
3,930,370
12.30%
112/09
469,649
-0.53%
344,482
36.33%
3,500,662
13.24%
112/08
472,133
-5.72%
415,238
13.70%
3,031,013
10.34%
112/07
500,804
30.71%
263,424
90.11%
2,558,881
9.74%
112/06
383,148
28.75%
342,722
11.80%
2,058,077
-0.49%
112/05
297,594
-4.02%
335,307
-11.25%
1,674,929
-2.93%
112/04
310,062
-45.19%
365,709
-15.22%
1,377,335
-0.93%
112/03
565,717
92.28%
479,433
18.00%
1,067,273
4.17%
112/02
294,217
41.90%
218,138
34.88%
501,556
-7.99%
112/01
207,339
-60.81%
326,974
-36.59%
207,339
-36.59%
111/12
529,050
31.04%
395,359
33.82%
4,432,801
-2.03%
111/11
403,723
-1.19%
346,880
16.39%
3,903,751
-5.46%
111/10
408,602
18.61%
416,617
-1.92%
3,500,028
-7.46%
111/09
344,482
-17.04%
353,278
-2.49%
3,091,426
-8.15%
111/08
415,238
57.63%
372,934
11.34%
2,746,945
-8.81%
111/07
263,424
-23.14%
384,511
-31.49%
2,331,707
-11.66%
111/06
342,722
2.21%
238,655
43.61%
2,068,283
-8.28%
111/05
335,307
-8.31%
343,992
-2.52%
1,725,561
-14.42%
111/04
365,709
-23.72%
885,445
-58.70%
1,390,254
-16.87%
111/03
479,433
119.78%
354,433
35.27%
1,024,545
30.20%
111/02
218,138
-33.29%
170,999
27.57%
545,112
26.05%
111/01
326,974
-17.30%
326,974
110/12
395,359
13.98%
4,524,568
110/11
346,880
-16.74%
4,129,209
110/10
416,617
17.93%
3,782,329
110/09
353,278
-5.27%
3,365,712
110/08
372,934
-3.01%
3,012,434
110/07
384,511
61.12%
2,639,500
110/06
238,655
-30.62%
2,254,989
110/05
343,992
-61.15%
2,016,334
110/04
885,445
149.82%
1,672,342
110/03
354,433
107.27%
786,897
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
